Evidence map›Paper›PMID 32748873›Full record

ArticleMaterials (Basel, Switzerland)2020

Synthesis and Antibacterial Activity of (AgCl, Ag)NPs/Diatomite Hybrid Composite.

Zhanar Kubasheva, Myroslav Sprynskyy, Viorica Railean-Plugaru, Paweł Pomastowski, Aliya Ospanova, Bogusław Buszewski

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Preparation of a BiRSC advances · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhanar KubashevaFaculty of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.
Myroslav SprynskyyDepartment of Environmental Chemistry and Bioanalytics, Faculty of Chemistry, Nicolaus Copernicus University in Torun, 87-100 Torun, Poland.
Viorica Railean-PlugaruInterdisciplinary Center for Modern Technologies, Nicolaus Copernicus University in Torun, 87-100 Torun, Poland.
Paweł PomastowskiInterdisciplinary Center for Modern Technologies, Nicolaus Copernicus University in Torun, 87-100 Torun, Poland.
Aliya OspanovaFaculty of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.
Bogusław BuszewskiDepartment of Environmental Chemistry and Bioanalytics, Faculty of Chemistry, Nicolaus Copernicus University in Torun, 87-100 Torun, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

. In the present research, hybrid (AgCl, Ag)NPs/diatomite composites were synthesized by direct impregnation with aqueous silver nitrate solutions. The silver chloride nanoparticles (AgCl-NPs) were formed as an effect of the exchange reaction when silver interacted with the diatomite mineral impurity halite. Nanoparticles of metallic silver (AgNPs) were created by the reduction of silver ions under the influence of hydrogen peroxide. The content of silver chloride nanoparticles in the (AgCl, Ag)NPs/diatomite composite was limited by the content of the halite in the used diatomite. Samples of natural diatomite and synthesized (AgCl, Ag)NPs/diatomite composites were examined by using scanning electron microscopy, transmission electron microscopy, X-ray powder diffraction, infrared spectroscopy and thermogravimetric analysis. Moreover, the antibacterial potential of synthesized composites was also studied using the MIC (minimal inhibitory concentration) method against the most common drug-resistant microorganisms in the medical field: Gram-positive

Indexed as

(AgCl, Ag)NPs/diatomite compositeantibacterial activitydiatomitesilver nanoparticles

Identifiers

PMID32748873
PMCPMC7435914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.